New Products

Cat. No.	Product Name	Target	Research Area	Added	Chemical Structure

HY-183834	PROTAC STAT6 degrader-7	PROTACs; STAT	Cancer	2026-06
HY-124405	P2Y1 antagonist 6	P2Y Receptor	Cardiovascular Disease	2026-06
HY-183934	Anti-inflammatory agent 99	Drug Derivative; NF-κB; JNK; ERK; p38 MAPK; TNF Receptor; Interleukin Related	Inflammation/Immunology	2026-06
HY-183960	BPyO-34	ASK1	Metabolic Disease; Inflammation/Immunology; Cancer	2026-06
HY-206259	CCG-203586	Glucosylceramide Synthase (GCS)	Metabolic Disease	2026-06
HY-183885	MPI3	SARS-CoV	Inflammation/Immunology; Infection	2026-06
HY-184073	Mal-PEG8-CO-Ala-Ala-Asp-MAA	Biochemical Assay Reagents	Cancer	2026-06
HY-145584A	Nesuparib hydrochloride	PARP; Wnt; β-catenin	Cancer	2026-06
HY-183667	JNJ-pan-AR	Androgen Receptor; Kallikrein	Cancer	2026-06
HY-N19944	Odoroside	Others	Others	2026-06
HY-183833	Autophagy-IN-9	Autophagy	Infection	2026-06
HY-184129	IDO1/TDO-IN-15	Indoleamine 2,3-Dioxygenase (IDO)	Neurological Disease; Cancer	2026-06
HY-105088C	Pexiganan TFA	Bacterial	Infection	2026-06
HY-125404	DAPK-IN-1	DAPK	Neurological Disease; Metabolic Disease; Cardiovascular Disease	2026-06
HY-183766	HYF038	ASK1	Neurological Disease	2026-06
HY-183825	Eleven-Nineteen-Leukemia Protein IN-4	Epigenetic Reader Domain; c-Myc	Cancer	2026-06
HY-N19936	Qinyangshengenin-3-O-β-D-digitoxopyranoside	Drug Derivative	Cancer	2026-06
HY-183809	ZSW	Hexokinase	Inflammation/Immunology	2026-06
HY-183801	Cu2LCl2(H2O)	Phosphatase; Apoptosis	Cancer	2026-06
HY-130305	GSK-938890A	PKC	Cancer	2026-06

Name
Email *

	Sorry, but the email address you supplied was invalid.